Guidelines

A-118 PERFORMANCES EVALUATION OF A NEW COAGULATION ANALYSER, STA R MAX® 2

February 2018
A-119 A PATIENT WITH A TYPE 2 CB VON WILLEBRAND DISEASE: LABORATORY DIAGNOSIS AND RESPONSE TO DESMOPRESSIN

February 2018
A-142 MAJOR AUTOANTIBODY REACTIVITY SEROLOGY AND MINOR SYMPTOMS IN A SLE PATIENT : A CASE REPORT

February 2018
A-105 PRE-ANALYTICAL STABILITY OF COAGULATION PARAMETERS IN PLASMA STORED AT ROOM TEMPERATURE

February 2018
A-143 ROLE OF VON WILLEBRAND FACTOR IN ABDOMINAL AORTIC ANEURYSMS

February 2018
A-109 A PATIENT WITH ACQUIRED FACTOR X DEFICIENCY AND METASTATIC TRANSITIONAL CELL CARCINOMA OF THE BLADDER : IS THERE A LINK BETWEEN METASTASIS AND FACTOR DEFICIENCY IN SOLID TUMOURS?

February 2018
A-103 SYSTEMIC THROMBOLYSIS AND ENDOVASCULAR THROMBECTOMY IN SEVERE ACUTE ISCHEMIC STROKE AFTER DABIGATRAN REVERSAL WITH IDARUCIZUMAB

February 2018
A-131 SUCCESSFUL AND COST-EFFECTIVE USE OF FC-FUSED FIX DURING MAJOR ORTHOPAEDIC SURGERY

February 2018
A-139 ADAMTS13 IN EXPERIMENTAL MALARIA-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME

February 2018
A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY

February 2018

Top